Almost all eukaryotes need oxygen to maintain regular physiological activities. When the organism is under hypoxic situation for a persistent or periodic, it will induce irreversible physiological disorders and even pathological results. Hypoxia is closely related to the pathogenesis of metabolic diseases, cancer, chronic heart disease and kidney disease, myocardial ischemia, as well as reproductive diseases like preeclampsia and endometriosis. Therefore, monitoring and treatment of hypoxia have important implications for the pathophysiology of human-related diseases. Carbon dots (CDs) are emerging nanomaterials developed after 2004 with excellent performance, and have broad application potential in variousdomains likeoptical, biomedicine, energy. Advanced hypoxia therapeutics should be integrated with monitoring and treatment, and CDs with excellent performance are good potential options when sensing is combined with various therapeutic methods. Some researchers have also begun to carry out research in related fields and achieved some results. This article aims to clarify the various applications of CDs in hypoxia-related fields in recent years, including hypoxia sensing and hypoxia tumor theranostics. Finally, the possible challenges and prospects for the application of CDs in hypoxia-related fields are discussed.
ChenPSChiuWTHsuPL, et al.Pathophysiological implications of hypoxia in human diseases. J Biomed Sci2020; 27: 63.
2.
KeeleyTPMannGE. Defining physiological normoxia for improved translation of cell physiology to animal models and humans. Physiol Rev2019; 99: 161–234.
3.
SemenzaGL. Perspectives on oxygen sensing. Cell1999; 98: 281–284.
4.
SemenzaGL. HiF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol2000; 88: 1474–1480.
5.
SemenzaGL. Hypoxia-inducible factors in physiology and medicine. Cell2012; 148: 399–408.
6.
EltzschigHKCarmelietP. Hypoxia and inflammation. N Engl J Med2011; 364: 656–665.
7.
KieransSJTaylorCT. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology. J Physiol2021; 599: 23–37.
8.
DebenhamMSmuinJNGranthamT, et al.Hypoxia and standing balance. Eur J Appl Physiol2021; 121: 993–1008.
9.
Antuna-PuenteBFeveBFellahiS, et al.Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab2008; 34: 2–11.
10.
TrayhurnPWangBWoodIS. Hypoxia and the endocrine and signalling role of white adipose tissue. Arch Physiol Biochem2008; 114: 267–276.
11.
HalderSKMilnerR. Hypoxia in multiple sclerosis; Is it the chicken or the egg?Brain2021; 144: 402–410.
12.
SchitoLSemenzaGL. Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer2016; 2: 758–770.
13.
BelisarioDCKopeckaJPasinoM, et al.Hypoxia dictates metabolic rewiring of tumors: implications for chemoresistance. Cells-Basel2020; 9: 2598.
14.
BaderSBDewhirstMWHammondEM. Cyclic hypoxia: an update on its characteristics, methods to measure it and biological implications in cancer. Cancers (Basel)2020; 13: 23.
15.
WeiHBedjaDKoitabashiN, et al.Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-β signaling. Proc Natl Acad Sci USA2012; 109: E841–E850.
16.
DyavanapalliJJamesonHDergachevaO, et al.Chronic intermittent hypoxia-hypercapnia blunts heart rate responses and alters neurotransmission to cardiac vagal neurons. J Physiol2014; 592: 2799–2811.
17.
NormanJTClarkIMGarciaPL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int2000; 58: 2351–2366.
18.
PackerM. Mechanisms leading to differential hypoxia-inducible factor signaling in the diabetic kidney: modulation by SGLT2 inhibitors and hypoxia mimetics. Am J Kidney Dis2021; 77: 280–286.
19.
AbeHSembaHTakedaN. The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases. J Atheroscler Thromb2017; 24: 884–894.
20.
MaLZhangJLiuY. Roles and mechanisms of obstructive sleep apnea-hypopnea syndrome and chronic intermittent hypoxia in atherosclerosis: evidence and prospective. Oxid Med Cell Longev2016; 2016: 8215082–8215110.
21.
RathGAggarwalRJawanjalP, et al.HIF-1 alpha and placental growth factor in pregnancies complicated with preeclampsia: a qualitative and quantitative analysis. J Clin Lab Anal2016; 30: 75–83.
22.
WuMHHsiaoKYTsaiSJ. Hypoxia: the force of endometriosis. J Obstet Gynaecol Res2019; 45: 532–541.
23.
ZouMLiuWChenH, et al.Advances in nanomaterials for treatment of hypoxic tumor. Natl Sci Rev2021; 8: nwaa160.
24.
KongTLiuTZhangY, et al.Carbon dots with intrinsic theranostic properties for photodynamic therapy of oral squamous cell carcinoma. J Biomater Appl2022; 37: 850–858.
25.
WangBLuS. The light of carbon dots: from mechanism to applications. Matter2022; 5: 110–149.
26.
LinXXiongMZhangJ, et al.Carbon dots based on natural resources: synthesis and applications in sensors. Microchem J2021; 160: 105604.
27.
LiuJLiRYangB. Carbon dots: a new type of carbon-based nanomaterial with wide applications. ACS Cent Sci2020; 6: 2179–2195.
28.
DuJXuNFanJ, et al.Carbon dots for in vivo bioimaging and theranostics. Small2019; 15: e1805087.
29.
DeviPSainiSKimKH. The advanced role of carbon quantum dots in nanomedical applications. Biosens Bioelectron2019; 141: 111158.
30.
SharmaADasJ. Small molecules derived carbon dots: synthesis and applications in sensing, catalysis, imaging, and biomedicine. J Nanobiotechnology2019; 17: 92.
31.
SajjadFHanYBaoL, et al.The improvement of biocompatibility by incorporating porphyrins into carbon dots with photodynamic effects and pH sensitivities. J Biomater Appl2022; 36: 1378–1389.
32.
MehtaAMishraABasuS, et al.Band gap tuning and surface modification of carbon dots for sustainable environmental remediation and photocatalytic hydrogen production-a review. J Environ Manage2019; 250: 109486.
33.
LiSZhangZ. Recent advances in the construction and analytical applications of carbon dots-based optical nanoassembly. Talanta2021; 223: 121691.
34.
HuangDChenYChengM, et al.Carbon dots-decorated carbon-based metal-free catalysts for electrochemical energy storage. Small2021; 17: e2002998.
35.
Liu YuanLWWHLiWWuH, et al.Carbon dots enhance ruthenium nanoparticles for efficient hydrogen production in alkaline. Acta Phys-Chim Sin2021; 37: 2009082–2009090.
36.
WuHLuSYangB. Carbon-dot-enhanced electrocatalytic hydrogen evolution. Acc Mater Res2022; 3: 319–330.
37.
ChengRXiangYGuoR, et al.Structure and interface modification of carbon dots for electrochemical energy application. Small2021; 17: e2102091.
MishraVPatilAThakurS, et al.Carbon dots: emerging theranostic nanoarchitectures. Drug Discov Today2018; 23: 1219–1232.
43.
WeiZWangBHongD, et al.Rational building of nonblinking carbon dots via charged state recovery. J Phys Chem Lett2021; 12: 8614–8620.
44.
GodavarthiSMohanKKVázquezVE, et al.Nitrogen doped carbon dots derived from sargassum fluitans as fluorophore for DNA detection. J Photochem Photobiol B2017; 172: 36–41.
45.
HanGZhaoJZhangR, et al.Membrane-penetrating carbon quantum dots for imaging nucleic acid structures in live organisms. Angew Chem Int Ed Engl2019; 58: 7087–7091.
46.
PlácidoJBustamante-LópezSMeissnerKE, et al.Microalgae biochar-derived carbon dots and their application in heavy metal sensing in aqueous systems. Sci Total Environ2019; 656: 531–539.
47.
WangZHuTLiangR, et al.Application of zero-dimensional nanomaterials in biosensing. Front Chem2020; 8: 320.
48.
FengHQianZ. Functional carbon quantum dots: a versatile platform for chemosensing and biosensing. Chem Rec2018; 18: 491–505.
49.
JiCZhouYLeblancRM, et al.Recent developments of carbon dots in biosensing: a review. ACS Sens2020; 5: 2724–2741.
50.
HuangQLinXChenD, et al.Carbon dots/α-Fe2O3-Fe3O4 nanocomposite: efficient synthesis and application as a novel electrochemical aptasensor for the ultrasensitive determination of aflatoxin B1. Food Chem2022; 373: 131415.
51.
XiaoCLaiLZhangL, et al.Spectroscopic and isothermal titration calorimetry studies of binding interactions between carbon nanodots and serum albumins. J Solution Chem2018; 47: 1438–1448.
52.
ParvinNMandalT. Dually emissive P, N-co-doped carbon dots for fluorescent and photoacoustic tissue imaging in living mice. Microchim Acta2017; 184: 1125.
53.
YangDGuanSNiuY, et al.Construction of a hypoxia responsive upconversion nanosensor for tumor imaging by fluorescence resonance energy transfer from carbon dots to ruthenium complex. J Mater Chem B2018; 6: 2315–2322.
54.
DengYZhaoDChenX, et al.Long lifetime pure organic phosphorescence based on water soluble carbon dots. Chem Commun (Camb)2013; 49: 5751–5753.
55.
GeJLanMZhouB, et al.A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation. Nat Commun2014; 5: 4596.
56.
JiaQGeJLiuW, et al.A magnetofluorescent carbon dot assembly as an acidic H(2)O(2)-driven oxygenerator to regulate tumor hypoxia for simultaneous bimodal imaging and enhanced photodynamic therapy. Adv Mater2018; 30: e1706090.
57.
DuXYWangCFWuG, et al.The rapid and large-scale production of carbon quantum dots and their integration with polymers. Angew Chem Int Ed Engl2021; 60: 8585–8595.
58.
HuangYHeNKangQ, et al.A carbon dot-based fluorescent nanoprobe for the associated detection of iron ions and the determination of the fluctuation of ascorbic acid induced by hypoxia in cells and in vivo. Analyst2019; 144: 6609–6616.
59.
SundaramAPengLChaiL, et al.Advanced nanomaterials for hypoxia tumor therapy: challenges and solutions. Nanoscale2020; 12: 21497–21518.
60.
TinganelliWDuranteM. Tumor hypoxia and circulating tumor cells. Int J Mol Sci2020; 21: 9592.
61.
YouLWuWWangX, et al.The role of hypoxia-inducible factor 1 in tumor immune evasion. Med Res Rev2021; 41: 1622–1643.
62.
SemenzaGL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer2003; 3: 721–732.
XuCNamJHongH, et al.Positron emission tomography-guided photodynamic therapy with biodegradable mesoporous silica nanoparticles for personalized cancer immunotherapy. ACS Nano2019; 13: 12148–12161.
65.
QiSGuoLYanS, et al.Hypocrellin A-based photodynamic action induces apoptosis in a549 cells through ros-mediated mitochondrial signaling pathway. Acta Pharm Sin B2019; 9: 279–293.
66.
WangLMengDHaoY, et al.Gold nanostars mediated combined photothermal and photodynamic therapy and X-ray imaging for cancer theranostic applications. J Biomater Appl2015; 30: 547–557.
67.
Van StratenDMashayekhiVDe BruijnHS, et al.Oncologic photodynamic therapy: basic principles, current clinical status and future directions. Cancers2017; 9: 19.
68.
KamkaewAChenFZhanY, et al.Scintillating nanoparticles as energy mediators for enhanced photodynamic therapy. ACS Nano2016; 10: 3918–3935.
69.
HongEJChoiDGShimMS. Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials. Acta Pharm Sin B2016; 6: 297–307.
70.
LuckySSSooKCZhangY. Nanoparticles in photodynamic therapy. Chem Rev2015; 115: 1990–2042.
71.
SunYZhaoDWangG, et al.Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development. Acta Pharm Sin B2020; 10: 1382–1396.
72.
LiYZhengXZhangX, et al.Porphyrin-based carbon dots for photodynamic therapy of hepatoma. Adv Healthc Mater2017; 6: 1600924.
73.
ZhengDWLiBLiCX, et al.Carbon-dot-decorated carbon nitride nanoparticles for enhanced photodynamic therapy against hypoxic tumor via water splitting. ACS Nano2016; 10: 8715–8722.
74.
DuanXChanCLinW. Nanoparticle-mediated immunogenic cell death enables and potentiates cancer immunotherapy. Angew Chem Int Ed2019; 58: 670–680.
75.
PietrobonVMarincolaFM. Hypoxia and the phenomenon of immune exclusion. J Transl Med2021; 19: 9.
76.
ZhangMWangWWuF, et al.Biodegradable poly(γ-glutamic acid)@glucose oxidase@carbon dot nanoparticles for simultaneous multimodal imaging and synergetic cancer therapy. Biomaterials2020; 252: 120106.
77.
YaoHZhangSGuoX, et al.A traceable nanoplatform for enhanced chemo-photodynamic therapy by reducing oxygen consumption. Nanomedicine-UK2019; 20: 101978.
78.
SunSChenJJiangK, et al.Ce6-modified carbon dots for multimodal-imaging-guided and single-NIR-laser-triggered photothermal/photodynamic synergistic cancer therapy by reduced irradiation power. ACS Appl Mater Inter2019; 11: 5791–5803.
79.
HouLChenDWangR, et al.Transformable honeycomb-like nanoassemblies of carbon dots for regulated multisite delivery and enhanced antitumor chemoimmunotherapy. Angew Chem Int Ed Engl2021; 60: 6581–6592.
80.
WeiZYinXCaiY, et al.Antitumor effect of a Pt-loaded nanocomposite based on graphene quantum dots combats hypoxia-induced chemoresistance of oral squamous cell carcinoma. Int J Nanomedicine2018; 13: 1505–1524.
81.
CastellsMThibaultBDelordJP, et al.Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death. Int J Mol Sci2012; 13: 9545–9571.
